VPS71 Antibody

What is VPS71 and how does it relate to other VPS family proteins?

VPS71 belongs to the vacuolar protein sorting (VPS) protein family, which plays crucial roles in intracellular molecular transport between organelles. Similar to other VPS proteins like VPS72, it likely participates in protein trafficking pathways. Research on the VPS family has shown that these proteins can be significantly overexpressed in certain cancer tissues compared to normal tissues, suggesting potential roles in disease processes . The VPS protein family includes at least 75 members (VPS1-VPS75) based on genomic screening in Saccharomyces cerevisiae, with many having homologs in human cells .

What are the common applications for VPS71 antibodies in research?

VPS71 antibodies are primarily used for:

• Detection of VPS71 protein expression in tissues and cell lines via Western blotting

• Immunoprecipitation to study protein-protein interactions

• Immunohistochemistry to examine tissue distribution patterns

• Chromatin immunoprecipitation studies, as VPS proteins may participate in nuclear processes

• Flow cytometry for cellular analyses

Similar to studies with other VPS proteins, researchers often use these antibodies to investigate correlations between protein expression and clinicopathological factors in disease states .

What are the key considerations for validating a VPS71 antibody?

When validating a VPS71 antibody, researchers should:

• Perform Western blot analysis to confirm specificity (single band at expected molecular weight)

• Include positive and negative controls (tissues/cells known to express or not express VPS71)

• Conduct peptide competition assays to confirm binding specificity

• Test cross-reactivity with other VPS family members, particularly VPS72 which shows high homology

• Validate antibody performance in all intended applications (WB, IHC, IF, etc.)

Research on VPS72 demonstrates that validation against tissue samples with established expression patterns is essential for confirming antibody specificity .

How can I optimize VPS71 antibody-based co-immunoprecipitation to identify novel protein interactions?

For optimized co-immunoprecipitation with VPS71 antibodies:

• Lysis buffer optimization: Use buffers containing 0.2% Triton X-100 and 0.1% NP-40 in PBS, similar to protocols used for other VPS protein studies .

• Cross-linking consideration: For transient interactions, consider using formaldehyde (0.1-1%) or DSP (dithiobis[succinimidyl propionate]) cross-linking.

• Control selection: Include IgG controls matched to the host species of your VPS71 antibody.

• Washing stringency: Implement a gradient washing strategy:

  • First wash: Low stringency buffer (150mM NaCl)

  • Middle washes: Medium stringency (300mM NaCl)

  • Final wash: PBS only

• Mass spectrometry preparation: For MS analysis, elute proteins using low pH glycine buffer (pH 2.5) rather than SDS to minimize contamination.

Based on studies with other VPS proteins, interactions may be concentration-dependent, with some VPS proteins showing both monomeric behavior and higher molecular mass complexes .

What approaches should be used to investigate the role of VPS71 in cancer progression similar to other VPS family members?

To investigate VPS71's potential role in cancer progression:

• Expression analysis pipeline:

  • Analyze transcriptomic databases (TCGA, ICGC) to identify differential expression between normal and cancer tissues

  • Validate findings using tissue microarrays with VPS71 antibody

  • Correlate expression with clinical parameters (tumor stage, grade, OS)

• Functional studies:

  • Generate stable knockdown and overexpression cell lines

  • Assess effects on proliferation, migration, invasion, and apoptosis

  • Evaluate response to chemotherapeutic agents

• Mechanistic investigations:

  • Conduct pathway analysis using phospho-specific antibodies

  • Perform ChIP-seq to identify potential DNA binding patterns

  • Analyze subcellular localization under various stress conditions

• In vivo validation:

  • Establish xenograft models with modulated VPS71 expression

  • Correlate tumor growth with VPS71 levels

Similar approaches have identified VPS72 as a potential independent risk factor for hepatocellular carcinoma prognosis through multivariate Cox analyses .

How does post-translational modification affect VPS71 antibody detection and what controls should be employed?

Post-translational modifications can significantly impact antibody detection of VPS71:

• Key modifications affecting detection:

  • Phosphorylation: May alter epitope accessibility

  • Ubiquitination: Can create additional bands on Western blots

  • SUMOylation: May mask epitopes in certain conformations

• Control implementation strategy:

  Modification	Positive Control	Negative Control	Validation Method
  Phosphorylation	Phosphatase-treated lysate	Phosphatase inhibitor treatment	Mobility shift assessment
  Ubiquitination	MG132-treated samples	Deubiquitinase treatment	Multiple band pattern analysis
  SUMOylation	SUMO protease treatment	SUMO inhibitor treatment	Size shift comparison

• Epitope masking assessment:

  • Compare multiple antibodies targeting different regions of VPS71

  • Use denaturing vs. native conditions to reveal masked epitopes

  • Employ different fixation protocols for IHC/IF to assess epitope accessibility

Research on VPS protein complexes suggests that modification states may influence complex formation and stability, potentially affecting antibody recognition .

What are the optimal conditions for using VPS71 antibodies in immunofluorescence studies of subcellular localization?

For optimal immunofluorescence with VPS71 antibodies:

• Fixation protocol optimization:

  • Test both 4% paraformaldehyde (20 minutes at room temperature) and methanol fixation (-20°C for 10 minutes)

  • For membrane proteins, include a mild permeabilization step (0.02% Triton X-100 and 0.01% NP-40 in PBS for 5 minutes)

• Blocking conditions:

  • Use a combination of 10% FBS plus 10% BSA in PBS for 1 hour to minimize background

  • Consider adding 0.1% fish gelatin for additional blocking efficacy

• Antibody incubation parameters:

  • Primary antibody: 1:100-1:500 dilution range, 37°C for 1 hour or 4°C overnight

  • Secondary antibody: Alexa Fluor 488 or 555-conjugated antibodies (1:500), 37°C for 1 hour

• Controls and counterstaining:

  • Include DAPI nuclear counterstain (5 minutes at room temperature)

  • Use antibodies against organelle markers for colocalization studies

• Image acquisition settings:

  • Collect Z-stack images (0.3-0.5 µm steps)

  • Perform deconvolution for improved resolution

  • Use confocal microscopy for precise localization analysis

These protocols are adapted from successful immunofluorescence approaches used with other VPS family proteins .

How should I troubleshoot weak or non-specific signals when using VPS71 antibodies in Western blotting?

When troubleshooting VPS71 antibody performance in Western blotting:

• Sample preparation optimization:

  Issue	Solution	Rationale
  Weak signal	Include protease inhibitors	Prevents degradation during lysis
  Multiple bands	Use freshly prepared samples	Minimizes degradation products
  No signal	Try different lysis buffers	Improves protein extraction
  High background	Pre-clear lysates	Removes non-specific binding proteins

• Transfer and blocking adjustments:

  • For hydrophobic proteins: Use PVDF membranes instead of nitrocellulose

  • Extend transfer time for large proteins (>100 kDa)

  • Test alternative blocking agents (5% milk vs. 5% BSA)

  • Include 0.1% Tween-20 in all washing steps

• Antibody optimization strategy:

  • Titrate primary antibody (1:500 to 1:5000)

  • Extend incubation time (overnight at 4°C)

  • Test different detection systems (HRP vs. fluorescent)

  • Consider signal amplification systems for low abundance proteins

• Positive control inclusion:

  • Use lysates from cells transfected with VPS71 expression vector

  • Include recombinant VPS71 protein as reference

When analyzing vacuolar protein sorting family proteins, some may exist in both monomeric forms and higher molecular weight complexes, which could explain multiple bands on Western blots .

What controls and validation steps are essential when using VPS71 antibodies in chromatin immunoprecipitation (ChIP) experiments?

For rigorous ChIP experiments with VPS71 antibodies:

• Essential controls:

  • Input DNA (typically 5-10% of starting material)

  • IgG negative control (matched to host species)

  • Positive control antibody (e.g., H3K4me3 for active promoters)

  • Positive control region (known binding site for transcription factors)

  • Negative control region (gene desert with no expected binding)

• Antibody validation procedure:

  • Pre-clear chromatin with protein A/G beads

  • Test antibody specificity via Western blot of nuclear extracts

  • Perform peptide competition assays to confirm specificity

  • Validate enrichment at positive control sites via qPCR before sequencing

• Cross-linking optimization:

  • Test multiple formaldehyde concentrations (0.5-1.5%)

  • Optimize cross-linking times (5-20 minutes)

  • Consider dual cross-linking with additional agents for protein-protein interactions

• Quality assessment metrics:

  • Signal-to-noise ratio (>5 for high-quality data)

  • Peak distribution relative to genomic features

  • Motif enrichment analysis in peak regions

  • Reproducibility between biological replicates (r > 0.8)

Studies on other VPS family proteins suggest they may participate in chromatin-associated processes, making ChIP protocols relevant for understanding their nuclear functions .

How does the function of VPS71 compare to other members of the VPS protein family in cellular pathways?

The VPS protein family consists of diverse members involved in intracellular trafficking and organelle biogenesis. Based on comparative analysis:

• Functional classification of VPS proteins:

  Class	Representative Members	Primary Function	VPS71 Relationship
  Class A	VPS1, VPS4	Vesicle formation	Potential indirect interaction
  Class B	VPS27, Hse1	Receptor cargo sorting	May share common pathways
  Class C	VPS11, VPS16	Fusion at vacuole	Distinct function expected
  Class D	VPS3, VPS6	Late Golgi trafficking	Parallel pathway involvement
  Class E	VPS23, VPS28	ESCRT components	Potential functional overlap
  Novel	VPS61-VPS75	Diverse functions	VPS71 belongs to this group

• Pathway involvement comparison:

  • Like VPS72, VPS71 may participate in cancer-related signaling pathways

  • While some VPS proteins like Vps27/Hse1 form stable complexes , others function independently

  • Genome-wide screens have identified 146 VPS genes in yeast, suggesting extensive functional diversity

• Evolutionary conservation analysis:

  • Core VPS functions are conserved from yeast to humans

  • Specialized functions have evolved in higher organisms

  • Novel VPS proteins (61-75) often show tissue-specific expression patterns

Notably, research indicates significant overexpression of 28 VPS family members in hepatocellular carcinoma tissues compared to normal tissues, suggesting potential conserved roles in cancer biology .

What experimental approaches should be used to distinguish between VPS71 and VPS72 functions given their potential structural similarity?

To differentiate VPS71 and VPS72 functions:

• Antibody specificity validation:

  • Perform side-by-side Western blots with both antibodies

  • Conduct peptide competition assays with specific peptides for each protein

  • Use knockout/knockdown validation in parallel experiments

• Differential expression analysis:

  • Compare tissue/cell type-specific expression patterns

  • Analyze developmental expression timing differences

  • Assess stress/stimuli-specific regulation

• Functional genomics approach:

  • Conduct CRISPR knockout screens for both genes

  • Perform rescue experiments with each protein

  • Use domain swapping to identify functional regions

• Structural biology comparison:

  • Generate recombinant proteins for structural studies

  • Compare binding kinetics to known partners

  • Assess post-translational modification patterns

Research on VPS72 has demonstrated its role as a potential independent risk factor for hepatocellular carcinoma prognosis , providing a foundation for comparative studies with VPS71.

What are the challenges and solutions for developing monoclonal versus polyclonal antibodies against VPS71?

Developing antibodies against VPS71 presents distinct challenges based on antibody type:

• Epitope selection considerations:

  Antibody Type	Optimal Epitopes	Challenges	Solutions
  Monoclonal	Linear, surface-exposed, unique regions	Limited epitope recognition	Epitope mapping using peptide arrays
  Polyclonal	Multiple regions across protein	Cross-reactivity with VPS72	Affinity purification against specific regions

• Production platform comparison:

  • Monoclonal: Hybridoma technology or phage display

  • Polyclonal: Immunization of rabbits, goats, or chickens

  • Consideration: Monoclonals offer consistency but polyclonals provide signal amplification

• Validation stringency requirements:

  • Monoclonals: Epitope mapping, cross-reactivity testing with similar VPS proteins

  • Polyclonals: Batch-to-batch variation testing, extensive pre-absorption controls

• Application-specific optimization:

  • Western blotting: Polyclonals often provide stronger signals

  • Immunoprecipitation: Monoclonals offer cleaner results

  • ChIP: Monoclonals preferred for consistency

  • Structural studies: Neutralizing monoclonals may provide conformation insights

Studies with other proteins have shown that careful selection of immunization strategies, including using virus-like particles as carriers, can improve antibody specificity and functionality .

How can VPS71 antibodies be utilized in studying protein degradation pathways in neurodegenerative diseases?

VPS71 antibodies can provide valuable insights into protein degradation pathways relevant to neurodegeneration:

• Autophagy pathway investigation:

  • Use VPS71 antibodies to monitor autophagosome formation

  • Track colocalization with LC3-positive structures

  • Assess VPS71 levels in response to autophagy inducers/inhibitors

• Protein aggregation studies:

  • Examine VPS71 distribution in relation to protein aggregates

  • Monitor interactions with known aggregation-prone proteins

  • Assess changes in VPS71 localization during disease progression

• Lysosomal function assessment:

  • Track VPS71 trafficking to lysosomes under stress conditions

  • Examine relationships with lysosomal membrane proteins

  • Quantify colocalization with degraded protein substrates

• Neuronal transport analysis:

  • Visualize VPS71-positive vesicles in axonal transport

  • Track movement patterns in live neurons using fluorescently tagged antibodies

  • Compare transport defects across disease models

VPS proteins play crucial roles in intracellular molecular transport between organelles , suggesting potential involvement in the protein clearance defects observed in neurodegenerative conditions.

What are the best practices for using VPS71 antibodies in multiplexed imaging techniques?

For optimal multiplexed imaging with VPS71 antibodies:

• Panel design considerations:

  • Select antibodies from different host species to avoid cross-reactivity

  • Choose fluorophores with minimal spectral overlap

  • Include nuclear and organelle markers for spatial context

• Sequential staining protocol:

  • Apply primary antibodies sequentially with glycine elution (100mM, pH 2.5) between rounds

  • Use direct conjugates when possible to reduce background

  • Include stringent washing steps (0.1% Triton X-100 in PBS, 3×5 minutes)

• Signal amplification strategies:

  • For low abundance targets: TSA (tyramide signal amplification)

  • For medium abundance: Secondary antibody amplification

  • For high abundance: Direct conjugated antibodies

• Advanced imaging approaches:

  • CODEX: For highly multiplexed tissue imaging (>40 markers)

  • CycIF: For iterative fluorescence imaging

  • IMC: For antibody-based mass cytometry imaging

• Data analysis workflow:

  • Cell segmentation based on membrane or nuclear markers

  • Quantification of marker colocalization

  • Spatial relationship mapping between VPS71 and other markers

These approaches build upon established immunofluorescence protocols that have been successful with other VPS family proteins .

What are the current knowledge gaps regarding VPS71 function and how can antibody-based approaches address them?

Current knowledge gaps and antibody-based solutions include:

• Unresolved functional questions:

  • VPS71's precise role in protein trafficking pathways

  • Potential nuclear functions beyond trafficking

  • Tissue-specific roles in development and disease

• Antibody-based approaches to address gaps:

  • Proximity labeling with antibody-enzyme conjugates

  • VPS71 interactome mapping via IP-MS

  • Tissue and subcellular distribution analysis via IHC/IF

  • Conformational studies using conformation-specific antibodies

• Integration with emerging technologies:

  • Single-cell proteomics to assess cell-type specific functions

  • Spatial transcriptomics correlation with protein localization

  • CRISPR screens combined with antibody-based readouts

While studies have identified numerous VPS proteins (VPS1-VPS75) and demonstrated their potential roles in diseases like cancer , specific functional characterization of VPS71 remains an opportunity for future research.

How can researchers best interpret contradictory results when using different VPS71 antibodies in their experiments?

When faced with contradictory results using different VPS71 antibodies:

• Systematic validation approach:

  • Confirm epitope locations for each antibody

  • Verify specificity via knockdown/knockout controls

  • Test performance across multiple applications

• Reconciliation strategies for conflicting data:

  Type of Conflict	Investigation Approach	Potential Explanation
  Different band patterns	Epitope availability analysis	Post-translational modifications
  Different localizations	Fixation method comparison	Epitope masking in certain conditions
  Variable interaction partners	Buffer condition testing	Salt/detergent sensitivity of interactions
  Inconsistent phenotypes	Cell type-specific validation	Context-dependent functions

• Integration framework:

  • Consider each antibody as detecting a potentially different subpopulation

  • Use multiple antibodies targeting different regions in parallel

  • Incorporate orthogonal techniques (e.g., tagged constructs)

• Reporting standards:

  • Document complete antibody information (source, catalog #, lot)

  • Report all validation experiments performed

  • Include negative results and limitations

Research on VPS proteins has shown they can exist in different states, including monomeric forms and larger complexes , which may explain varying results with different antibodies.